|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
5R01CA185039-02
|
$373,133
|
$373,133
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cance
|
1R01CA194473-01
|
$386,514
|
$386,514
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
(PQB-2) ""Driver"" vs. ""passenger"" epigenetic events in Ewing sarcoma
|
7R01CA183776-03
|
$309,175
|
$309,175
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
|
(PQB-2) ""Driver"" vs. ""passenger"" epigenetic events in Ewing sarcoma
|
5R01CA183776-02
|
|
$0
|
LESSNICK, STEPHEN
|
UNIVERSITY OF UTAH
|
|
|
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
|
5R21CA189990-02
|
$232,616
|
$232,616
|
MURRAY, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-02
|
$324,033
|
$324,033
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatr
|
1R21CA198392-01
|
$199,665
|
$199,665
|
OTTO, MARIO
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
1R01CA190843-01
|
$325,389
|
$162,695
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
5R01CA174851-02
|
$535,247
|
$535,247
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma G
|
1F31CA200273-01
|
$43,120
|
$10,780
|
VENKATESH, HUMSA
|
STANFORD UNIVERSITY
|
|
|
A Novel Epigenetic Circuit in Acute Leukemia
|
5R21CA187276-02
|
$203,580
|
$203,580
|
HUANG, GANG
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
A novel functional genomic pipeline for target identification in sarcoma
|
5R21CA187516-02
|
$165,530
|
$165,530
|
AMATRUDA, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
A Novel Mobile Health Fitness Program for AYA Childhood Cancer Survivors
|
5K07CA174728-02
|
$164,851
|
$164,851
|
DEVINE, KATIE
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
5K07CA178100-03
|
$130,652
|
$130,652
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
A role for notch in self renewal in embryonal rhabdomyosarcoma
|
5K99CA175184-02
|
$180,360
|
$180,360
|
IGNATIUS, MYRON
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
$10,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
$20,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$1,232,700
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-05
|
$325,282
|
$325,282
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$522,314
|
$261,157
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,731,003
|
$51,930
|
Rosenberg, Steven
|
CCR (NCI)
|
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$707,219
|
$707,219
|
Fry, Terry
|
CCR (NCI)
|
|
|
ALL immunobiology and the bone marrow niche
|
ZIA BC 011295
|
$303,094
|
$303,094
|
Fry, Terry
|
CCR (NCI)
|
|
|
ALL therapy and developing brains: MRI measures, genetic factors and cognition
|
5R01CA090246-10
|
$380,224
|
$380,224
|
REDDICK, WILBURN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-05
|
$170,100
|
$85,050
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
|
5R01CA170250-04
|
$584,002
|
$584,002
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
5R01CA129541-09
|
$162,884
|
$81,442
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
An investigation of Radial Glia as the source of Ependymoma Stem Cells
|
7R01CA129541-10
|
$159,641
|
$79,821
|
GILBERTSON, RICHARD
|
UNIVERSITY OF CAMBRIDGE
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,007,151
|
$100,715
|
Oberholtzer, J.
|
CCR (NCI)
|
|
|
Anticancer Drug Pharmacology in Very Young Children
|
5R01CA154619-04
|
$433,475
|
$433,475
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,372,042
|
$47,441
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
ARID5B and disparities of childhood leukemia
|
3U01CA176063-02S1
|
$98,461
|
$98,461
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
ARID5B and disparities of childhood leukemia
|
5U01CA176063-02
|
$377,891
|
$377,891
|
YANG, JUN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
1R01CA191077-01
|
$295,711
|
$295,711
|
NAPPER, ANDREW
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
Assisted Reproductive Technology & Risk of Childhood Cancer
|
5R01CA151973-05
|
$567,219
|
$567,219
|
LUKE, BARBARA
|
MICHIGAN STATE UNIVERSITY
|
|
|
ATR: a novel therapeutic target for medulloblastoma identified by its role in cer
|
1F30CA192832-01
|
$33,358
|
$33,358
|
LANG, YUN LONG
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-02
|
$667,500
|
$166,875
|
GREIF, JON
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$662,584
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$23,552
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$38,440
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Berberine downregulates MDM2 by interaction with DAXX in cancer cells
|
5R01CA143107-06
|
$237,269
|
$237,269
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS
|
ZIA BC 011002
|
$359,862
|
$359,862
|
Khan, Javed
|
CCR (NCI)
|
|
|
Biology and Prognostic Implications of FLT3 Mutations in AML
|
5R01CA114563-09
|
$429,307
|
$214,654
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$376,957
|
$376,957
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Biomarkers in pediatric versus adult myelodysplastic syndromes
|
1R03CA195618-01
|
$76,000
|
$38,000
|
VERNERIS, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$561,071
|
$56,107
|
Steinberg, Seth
|
CCR (NCI)
|
|
|
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
|
5R01CA168452-03
|
$261,619
|
$261,619
|
CHOU, MARGARET
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
5K07CA166177-03
|
$164,937
|
$164,937
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation
|
5R01CA174794-03
|
$642,665
|
$642,665
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Brain Tumor Animal Therapeutics Core (Scientific Cores)
|
ZIC BC 011641
|
$399,559
|
$119,868
|
Gilbert, Mark
|
CCR (NCI)
|
|
Total relevant funding to Childhood Cancers for this search: $205,060,620
|
